Abstract
OCCUPANCY of the T-cell antigen receptor is insufficient to induce T-cell activation optimally; a second co-stimulatory signal is required1. Exposure of T-cell clones to complexes of antigen with major histocompatibility complex molecules in the absence of the co-stimulatory signal induces a state of clonal anergy. This requirement for two stimuli for T-cell activation could have an important role in vivo in establishing peripheral tolerance to antigens not encountered in the thymus1,2. The receptor on T cells required for the co-stimulatory stimulus involved in the prevention of anergy has not been identified. The human T-cell antigen CD28 provides a signal that can synergize with T-cell antigen receptor stimulation in activating T cells to proliferate and secrete lymphokines3–6. Here we report that a monoclonal antibody against the murine homologue of CD28 (ref. 7; J.A.G. et al., manuscript in preparation) can provide a co-stimulatory signal to naive CD4+ T cells and to T-cell clones. Moreover, we demonstrate that this co-stimulatory signal can block the induction of anergy in T-cell clones.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mueller, D. L., Jenkins, M. K. & Schwartz, R. H. A. Rev. Immun. 7, 445–480 (1989).
Schwartz, R. H. Science 248, 1349–1356 (1990).
Hansen, J. A., Martin, P. J. & Nowinski, R. C. Immunogenetics 10, 247–260 (1980).
Martin, P. J. et al. J. Immun. 136, 3282–3287 (1986).
Weiss, A., Manager, B. & Imboden, J. J. Immun. 137, 819–825 (1986).
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. Molec. cell. Biol. 7, 4472–4481 (1987).
Gross, J. A., St. John, T. & Allison, J. P. J. Immun. 144, 3201–3210 (1990).
Gunter, K. C., Malek, T. R. & Shevach, E. M. J. exp. Med. 159, 716–730 (1984).
Gunter, K. C. et al. Nature 326, 505–507 (1987).
Jenkins, M. K. & Schwartz, R. H. J. exp. Med. 165, 302–319 (1987).
Otten, G. R. & Germain, R. N. Science 251, 1228–1231 (1991).
Jenkins, M. K., Ashwell, J. D. & Schwartz, R. H. J. Immun. 140, 3324–3330 (1988).
Linsley, P. S., Clark, E. A. & Ledbetter, J. A. Proc. natn. Acad. Sci. U.S.A. 87, 5031–5035 (1990).
Freeman, G. J. et al. J. exp. Med. 174, 625–631 (1991).
Linsley, P. S. et al. J. exp. Med. 173, 721–730 (1991).
Gimmi, C. D. et al. Proc. natn. Acad. Sci. U.S.A. 88, 6575–6579 (1991).
Jenkins, M. K., Taylor, P. S., Norton, S. D. & Urdahl, K. B. J. Immun. 147, 2461–2466 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harding, F., McArthur, J., Gross, J. et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607–609 (1992). https://doi.org/10.1038/356607a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/356607a0
This article is cited by
-
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Journal of Translational Medicine (2023)
-
Chimeric antigen receptor T cells therapy in solid tumors
Clinical and Translational Oncology (2023)
-
Leveraging mesoporous silica nanomaterial for optimal immunotherapeutics against cancer
In vitro models (2023)
-
Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation
Cell & Bioscience (2022)
-
CAR-T cell potency: from structural elements to vector backbone components
Biomarker Research (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.